Publications by authors named "Iside Alessi"

Claim this Profile
T
The Prognostic Role of the C-Reactive Protein and Serum Lactate Dehydrogenase in a Pediatric Series of Bone Ewing Sarcoma.
Giada Del Baldo, Rachid Abbas, Maria Antonietta De Ioris, Valentina Di Ruscio, Iside Alessi

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response to crizotinib in a 17-year-old boy with treatment-naïve ALK-positive non-small-cell lung cancer.
Giacomina Megaro, Evelina Miele, Gian Paolo Spinelli, Iside Alessi, Giada Del Baldo

Cancer Rep (Hoboken)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage.
Iside Alessi, Anna Maria Caroleo, Luca de Palma, Angela Mastronuzzi, Stefano Pro, Alessia Carboni

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Concetta Quintarelli, Antonio Camera, Roselia Ciccone, Iside Alessi, Francesca Del Bufalo

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies.
Stefano Pro, Luciana Vinti, Alessandra Boni, Angela Mastronuzzi, Martina Scilipoti, Iside Alessi

J Clin Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of the clinical and molecular spectrum of an XPD-related disorder linked to biallelic mutations in ERCC2 gene.
Emanuele Agolini, Elena Botta, Mariachiara Lodi, Maria Cristina Digilio, Martina Rinelli, Iside Alessi

Clin Genet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experience.
Antonella Cacchione, Mariachiara Lodi, Andrea Carai, Evelina Miele, Marco Tartaglia, Iside Alessi, Alessia Carboni

Int J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review.
Marco Ranalli, Alessandra Boni, Anna Maria Caroleo, Giada Del Baldo, Martina Rinelli, Iside Alessi

Diagnostics (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medulloblastoma Associated with Down Syndrome: From a Rare Event Leading to a Pathogenic Hypothesis.
Alessandra Boni, Marco Ranalli, Giada Del Baldo, Roberto Carta, Mariachiara Lodi, Iside Alessi

Diagnostics (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management.
Giada Del Baldo, Roberto Carta, Iside Alessi, Pietro Merli, Emanuele Agolini

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk.
Anna Maria Caroleo, Maria Antonietta De Ioris, Luigi Boccuto, Iside Alessi, Giada Del Baldo

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Virginia Di Paolo, Marta Colletti, Valentina Ferruzzi, Ida Russo, Angela Galardi, Iside Alessi

Curr Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell depleting immunotherapies: therapeutic opportunities and toxicities.
Francesca Del Bufalo, Pietro Merli, Iside Alessi, Franco Locatelli

Expert Rev Clin Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome.
Giuseppe Petruzzellis, Diletta Valentini, Francesca Del Bufalo, Giulia Ceglie, Andrea Carai, Iside Alessi

Front Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review.
Giuseppe Petruzzellis, Iside Alessi, Giovanna Stefania Colafati, Francesca Diomedi-Camassei, Andrea Ciolfi

Front Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V600E Inhibitor (Vemurafenib) for V600E Mutated Low Grade Gliomas.
Francesca Del Bufalo, Giulia Ceglie, Antonella Cacchione, Iside Alessi, Giovanna Stefania Colafati

Front Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis